The Pink Pineapple Podcast

In Slice Thirteen of The Pink Pineapple Podcast, Emma and Claudia are joined by Michelle Griffin, a former obstetrician-gynaecologist turned health tech advisor, to talk about fibroids - one of the most common yet least understood conditions affecting women.

They explore why fibroids are so often normalised, what symptoms women are expected to tolerate, and how gaps in education and diagnosis continue to delay care. Michelle shares her journey from clinical medicine into health tech, and why better tools, clearer communication and earlier education could radically change how fibroids are understood and treated.

A thoughtful, honest conversation about moving beyond “it’s just normal” - and towards better understanding and better solutions.

In this episode, we’re joined by Dr Julie Hammond, GP, CEO of Mamar, and maternal health advocate, for a deeply honest conversation about pregnancy loss, neurodiversity, and why postnatal care so often fails women.

We talk about the silence around loss, the mental load of early motherhood, cultural sensitivity in care, and why mothers themselves are still too easily overlooked by health systems. Julie also shares how Mamar was built to close these gaps - with practical, compassionate support that fits into real lives.

This is an episode about care, equity, and finally designing systems that hold women - not just babies.

In this episode of The Pink Pineapple Podcast, hosts Emma and Claudia are joined by Dr Derrick Khor - cancer doctor, health-tech consultant, and co-founder of Medical Consulting Group - for an honest and timely conversation about male allyship in women’s health and FemTech.

Derrick shares what drew him into advocating for women’s health, why allyship is more than performative support, and how men can use their visibility, influence, and capital responsibly in a space historically underfunded and over-policed.

Together, the trio unpack:

• what genuine allyship actually looks like in practice
• the ethics of investing in women’s health
• how consulting in women’s health is evolving
• and what aspiring health-tech professionals can do right now to contribute meaningfully

This is a thoughtful, nuanced discussion about power, responsibility, collaboration - and why progress in women’s health requires everyone to show up better.

In this episode of The Pink Pineapple Podcast, we’re joined by Dr Rosie Webster, behavioural scientist and health coach, to unpack why New Year’s resolutions (especially around weight) so often fail women (and men) - and what actually works instead.

This is a refreshingly honest conversation about:

• why January creates unrealistic pressure

• how “all-or-nothing” thinking sabotages behaviour change

• why weight-centric goals backfire

• how GLP-1s fit into (and sometimes worsen) the stigma conversation

• and what focusing on behaviours - not bodies - really means

It’s compassionate, evidence-based, and a much-needed antidote to diet culture noise.

We also discuss where health tech companies are going wrong in the ways they approach behaviour change and how to create impactful health tech products.

You can find Rosie and sign up for her January newsletters here: https://www.reframehealth.uk/

Instagram: https://www.instagram.com/reframehealth.uk/

In this episode, Emma and Claudia reflect on the defining moments in women’s health and femtech in 2025. From the WHOOP controversy and the rise of GLP-1 medications to major funding commitments, censorship in women’s health, and the realities faced by female founders, they unpack what this year revealed about the evolving health-tech landscape — and what it might mean as we head into 2026.

In this episode, Emma and Claudia (Doctors and experienced health tech enthusiasts) unpack what it really takes to get into health tech. From personal branding and networking to transferable clinical skills and CVs that actually work, they share honest advice, common misconceptions, and practical steps for clinicians looking to make the move in 2026.

Endometriosis is still widely under-diagnosed, with many women facing years of uncertainty.

In this episode of The Pink Pineapple Podcast, Claudia and Emma speak to Molly Jowsey, co-founder of Revela.

We explore how technology and better data are changing the path to diagnosis — from patient insight to surgical planning — and where tools like Revela can genuinely make a difference.

We also discuss why women’s pain is so often underestimated, and how lived experience can drive smarter women’s health tech.

Phase co-founder Maggie McDaris joins us to discuss the link between hormones and how we think, feel, and work. We explore the evidence behind cycle-related cognitive changes and how Phase turns that science into practical insights. A smart, empowering conversation about understanding your biology and planning your month with more intention.

In this episode, Claudia and Emma sit down with Dr Eleonora Benhar from Natural Cycles to unpack the science behind the world’s first FDA-cleared digital contraceptive. They explore how the app uses temperature and menstrual data to accurately predict fertility, why cycle education is still so lacking, and how features like Go Anonymous protect user privacy. The conversation also looks ahead to wearables, perimenopause, and what the future of evidence-based women’s health tech might hold.

In this episode of The Pink Pineapple Podcast, Claudia and Emma sit down with Dr Fran Conti-Ramsden — obstetrics and gynaecology doctor, clinical researcher, and CMO of MEGI Health — for a powerful deep dive into one of the most misunderstood conditions in women’s health: preeclampsia.

Fran explains why this complex pregnancy disease looks different in every woman, why it can appear after birth, and how it dramatically increases long-term cardiovascular risk. The conversation uncovers the major blind spots in postpartum care, the overlooked importance of interpregnancy health, and why so many women are never told about the lifetime implications of preeclampsia.

We explore how MEGI Health is using AI, remote monitoring and smarter self-management tools to reshape the future of pregnancy hypertension — empowering patients, supporting clinicians, and helping prevent avoidable complications.

This episode shines a light on the huge research gap in women’s cardiovascular health, the inequities in funding, and why the next wave of innovation in maternal health must be data-driven, personalised and continuous — not just focused on pregnancy, but every stage before and after it.